Výsledky vyhledávání - "Gitta, Bleeker"

Akademický článek

A narrative review of 35 years of meta-[131I]iodobenzylguanidine therapy in neuroblastoma

Autor: Atia Samim, Gitta Bleeker, Kathelijne C.J.M. Kraal, Max M. van Noesel, Bart de Keizer, Godelieve A.M. Tytgat

Publikováno v: EJC Paediatric Oncology, Vol 3, Iss , Pp 100159- (2024)

Neuroblastoma is the most common extracranial solid malignancy of childhood. Approximately half of the patients have high-risk neuroblastoma (HR-NBL), typically presenting as widespread metastatic disease at diagnosis. Despite aggressive multimodalit

Externí odkaz: https://doaj.org/article/b93d47989bf542578c9e84319037595b

Zobrazit plný text záznamu

[Which imaging methods are safe in pregnant patients? A step-by-step plan to choose the right method]

Autor: Gitta, Bleeker, Alice M, Wagenvoort, Paul R, Algra

Publikováno v: Nederlands tijdschrift voor geneeskunde. 166

Diagnostic imaging in pregnant patients often causes worries about radiation effects and IV contrast. We use a step-by-step plan to choose the right method and illustrate this with a case. First, we choose the method of imaging, non-ionizing imaging

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b88f5b26c21c9c0c8a3d583de632c59d
https://pubmed.ncbi.nlm.nih.gov/35499549

Zobrazit plný text záznamu

Nuclear Medicine Imaging in Neuroblastoma: Current Status and New Developments

Autor: Max M. van Noesel, Nelleke Tolboom, Sylvia T M Wenker, Marnix G.E.H. Lam, Atia Samim, Bart de Keizer, Kristell L S Chatalic, Gitta Bleeker, Godelieve A.M. Tytgat, Alex J. Poot

Publikováno v: Journal of Personalized Medicine
Journal of Personalized Medicine, Vol 11, Iss 270, p 270 (2021)

Neuroblastoma is the most common extracranial solid malignancy in children. At diagnosis, approximately 50% of patients present with metastatic disease. These patients are at high risk for refractory or recurrent disease, which conveys a very poor pr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3be8c80ee49e4ee6c292943a076678f6
http://europepmc.org/articles/PMC8066332

Zobrazit plný text záznamu

Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients

Autor: F. Berthold, Godelieve A.M. Tytgat, Gitta Bleeker, N.K.A. van Eijkelenburg, Kathelijne C. J. M. Kraal, M.M. van Noesel, B. L. F. van Eck-Smit, H.N. Caron

Publikováno v: European journal of cancer (Oxford, England, 76, 188-196. Elsevier Limited
European Journal of Cancer, 76, 188-196. Elsevier Ltd.

Aim of the study Radiolabelled meta-iodobenzylguanidine (MIBG) is an effective option in treatment of neuroblastoma (NBL) tumours. We studied feasibility, toxicity and efficacy of upfront 131 I-MIBG and induction treatment in stage 4 NBL patients. Pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c81ba12f7a80e96bbc2115eeec7fa09
https://doi.org/10.1016/j.ejca.2016.12.013

Zobrazit plný text záznamu

MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis

Autor: Koos H. Zwinderman, Genevieve Laureys, Susan G. Kreissman, Ingrid Øra, Max M. van Noesel, Gertjan J.L. Kaspers, Boen L. Kam, Rogier Versteeg, Johannes H. Schulte, Berthe L. F. van Eck-Smit, Gregory A. Yanik, Barbara Hero, Godelieve A.M. Tytgat, Huib N. Caron, Bieke Lambert, Gitta Bleeker, Annelies van Schie, Matthias Schmidt

Publikováno v: European journal of nuclear medicine and molecular imaging, 42(2), 222-230. Springer Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 222-230. Springer-Verlag
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
European Journal of Nuclear Medicine and Molecular Imaging
Bleeker, G, Eck-Smit, B L, Zwinderman, K H, Versteeg, R, van Noesel, M M, Kam, B L, Kaspers, G J, van Schie, A, Kreissman, S G, Yanik, G, Hero, B, Schmidt, M, Laureys, G, Lambert, B, Ora, I, Schulte, J H, Caron, H N & Tytgat, G A 2015, ' MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 2, pp. 222-230 . https://doi.org/10.1007/s00259-014-2909-1
European Journal of Nuclear Medicine and Molecular Imaging, 42(2), 222-230. Springer Verlag

Purpose The aim of this study was to find clinically relevant MIBG-avid metastatic patterns in patients with newly diagnosed stage 4 neuroblastoma. Methods Diagnostic 123I-MIBG scans from 249 patients (123 from a European and 126 from the COG cohort)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d36eb195e126424aacf7bcfe007acbcd
https://doi.org/10.1007/s00259-014-2909-1

Zobrazit plný text záznamu

Toxicity of upfront 131I-metaiodobenzylguanidine (131I-MIBG) therapy in newly diagnosed neuroblastoma patients: a retrospective analysis

Autor: Cees A. Hoefnagel, Godelieve A.M. Tytgat, Berthe L. van Eck, Jan de Kraker, Reineke A. Schoot, Huib N. Caron, Gitta Bleeker

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging

Purpose In the treatment of patients with high-risk neuroblastoma, different doses of 131I-metaiodobenzylguanidine (131I-MIBG) are administered at different time points during treatment. Toxicity, mainly haematological (thrombocytopenia), from 131I-M

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94799888ebf5bde49431e5af1de9fbb9
https://doi.org/10.1007/s00259-013-2510-z

Zobrazit plný text záznamu

123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma

Autor: Judit A. Adam, Huib N Caron, Godelieve A.M. Tytgat, Elvira C. van Dalen, Lotty Hooft, Gitta Bleeker, Leontien C. M. Kremer

Publikováno v: The Cochrane Library
The Cochrane Database of Systematic Reviews
Cochrane Database of Systematic Reviews, 9, 1. John Wiley and Sons Ltd

Background Neuroblastoma is an embryonic tumour of childhood that originates in the neural crest. It is the second most common extracranial malignant solid tumour of childhood. Neuroblastoma cells have the unique capacity to accumulate Iodine-123-met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92d44a29c7f899adc4dd75058e021e12
https://doi.org/10.1002/14651858.cd009263.pub2

Zobrazit plný text záznamu

The role of I-131-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma

Autor: Berthe L. van Eck, Jan de Kraker, Huib N. Caron, Hugo A. Heij, Godelieve A.M. Tytgat, Reineke A. Schoot, Gitta Bleeker

Publikováno v: European Journal of Nuclear Medicine and Molecular Imaging, 40(10), 1516-1522. Springer Verlag
European journal of nuclear medicine and molecular imaging, 40(10), 1516-1522. Springer Verlag
Schoot, R A, Bleeker, G, Caron, H N, van Eck, B L, Heij, H A, de Kraker, J & Tytgat, G A 2013, ' The role of I-131-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma ', European Journal of Nuclear Medicine and Molecular Imaging, vol. 40, no. 10, pp. 1516-1522 . https://doi.org/10.1007/s00259-013-2455-2
European Journal of Nuclear Medicine and Molecular Imaging

Purpose In patients with localised neuroblastoma without adverse genetic aberrations, observational treatment is justified. Therapy is required when organ or respiratory functions have become compromised. As the outcome is good, side effects of treat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b8acd5c367d07dd99d8366c50a7ff8c
https://research.vumc.nl/en/publications/2290aa6a-81f2-478d-8bda-6b97ced42502

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání